These results suggested that ERRFI1 levels decrease in parallel with NAFLD/NASH disease progression, and MIG6/ERRFI1 suppression may contribute to HCC induction via EGFR degradation. The gene discussed is ERRFI1; the disease is metabolic dysfunction-associated steatohepatitis.